会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Method for the treatment and prevention of overweight in mammals
    • 治疗和预防哺乳动物超重的方法
    • US07214386B2
    • 2007-05-08
    • US10384750
    • 2003-03-11
    • Rene John RaggersGeorge Verlaan
    • Rene John RaggersGeorge Verlaan
    • A61K9/20
    • A61K36/185A61K36/23A61K36/77A61K36/82A61K36/9068A61K2300/00
    • The present invention relates to a method for the prevention and/or treatment of overweight in mammals. More particularly the invention is concerned with such a method comprising the enteral administration to a mammal of a preparation comprising an effective amount of a combination of dill or an isolate thereof and one or more components capable of stimulating in vivo lipolysis. Suitable examples of components capable of stimulating in vivo lipolysis include methylxanthines, adrenergic amines, Paullinia cupana or an isolate thereof, Zingziber officinale or an isolate thereof, Camellia sinensis or an isolate thereof, Ilex paraguayiensis or an isolate thereof.Another aspect of the invention relates to a solid or semi-solid unit dosage, preferably selected from the group consisting of tablets, pills, microparticles, microspheres, suppositories, capsules, caplets and the like, that is suitable for enteral unitary administration to human subjects and other mammals comprising: a. dill or an isolate thereof in an amount equivalent to between 5 mg and 20 g dill and b. a component capable of stimulating in vivo lipolysis.
    • 本发明涉及一种用于预防和/或治疗哺乳动物超重的方法。 更具体地,本发明涉及这样的方法,其包括向哺乳动物施用有效量的莳萝或其分离物的组合的一种或多种能够刺激体内脂肪分解的成分的哺乳动物的肠内施用。 能够刺激体内脂肪分解的组分的合适实例包括甲基黄嘌呤,肾上腺素能胺,保加利亚或其分离物,姜黄或其分离物,山茶或其分离物,白僵菌或其分离物。 本发明的另一方面涉及一种固体或半固体单位剂量,优选选自由片剂,丸剂,微粒,微球,栓剂,胶囊,囊片等组成的组,其适用于人受试者的肠内单一给药 和其他哺乳动物,包括:a。 莳萝或其分离物的量相当于5mg和20g莳萝之间,b。 能够刺激体内脂肪分解的成分。